DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.85

EPS Forecast

$17.14

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
TECHBio-techne CorpHALOHalozyme Therapeutics IncRGENRepligen CorpIOVAIovance Biotherapeutics IncNVAXNovavax IncBLUEBluebird Bio IncCRSPCrispr Therapeutics AgNBIXNeurocrine Biosciences IncMRNAModerna Inc